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Introduction

41
Although platinum metallo-drugs are among the most effective 42 agents for the treatment of cancer their clinical utility is restricted due 43 to the frequent development of drug resistance, the limited spectrum 44 of tumours against which these drugs are active and severe normal tis-45 sue toxicity being the nephrotoxicity an important side effect which in-
46
terferes with their therapeutic efficiency [1] [2] [3] [4] [5] .
47
Currently, metal complexes with structures different from that of 48 cisplatin are being considered with the idea that they would have a dif-49 ferent spectrum of activity and hence do not develop cross-resistance to 50 cisplatin [6, 7] . activity by themselves [14] . It has been demonstrated that the bio- 
253 254 where T is the mean absorbance of the treated cells and C the mean 255 absorbance in the controls.
256
The inhibitory potential of compounds was measured by calculat-
257
ing concentration-percentage inhibition curves, these curves were 258 adjusted to the following equation:
where E is the percentage inhibition observed, E max is the maximal ef-261 fects, IC 50 is the concentration that inhibits 50% of maximal growth, C
262
is the concentration of compounds tested and n is the slope of the 
265
For comparison purposes, the antiproliferative activity of cisplatin 266 was evaluated under the same experimental conditions. All Pd (1) Tables 1 and 2 . triazole moieties, the interplane separation being 3.35 Å is considered
353
optimal for π-π interactions (intramolecular stacking). This arrange- (SNN) and S-bridging modes in a similar manner to the above described bearing a triphenylphosphine coligand, displayed significant in vitro 
460
antiproliferative activity in the two ovarian carcinoma cell lines tested.
461
Specifically, complexes 9 and 10 showed the most promising results. In 
467
The compounds were also tested against NCI-H460 (non-small cell since all complexes tested presented, at 100 μM concentration, very 478 low cellular growth inhibition (b50%) and therefore had not evaluable 479 cytotoxicity (IC 50 N 100 μM).
480
As shows 
